X4 Pharmaceuticals (XFOR) Change in Acquisitions & Divestments (2023 - 2025)

X4 Pharmaceuticals' Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $18.8 million for Q4 2025.

• Quarterly Change in Acquisitions & Divestments rose 32.04% year-over-year to $18.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $74.5 million (up 181.82% YoY) and the FY2025 annual result came in at $74.5 million, up 181.82% from the prior year.
• Change in Acquisitions & Divestments was $18.8 million for Q4 2025 at X4 Pharmaceuticals, up from $15.9 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $28.2 million in Q2 2025 and bottomed at $1.0 million in Q3 2023.
• A 3-year average of $10.3 million and a median of $8.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments jumped 1320.0% — and 2025, when it soared 32.04%.
• X4 Pharmaceuticals' Change in Acquisitions & Divestments stood at $1.0 million in 2023, then soared by 1320.0% to $14.2 million in 2024, then soared by 32.04% to $18.8 million in 2025.
• Business Quant data shows XFOR's Change in Acquisitions & Divestments at $18.8 million in Q4 2025, $15.9 million in Q3 2025, and $28.2 million in Q2 2025.